$1.78 -0.05 (-2.73%)
11/25/2009 4:00 PM

AVANIR Pharmaceuticals (AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Featured Broker Partners